Skip to content
My WebMD Sign In, Sign Up

Parkinson's Disease Health Center

Font Size

Senate Passes New Stem Cell Bill

But Tally Falls Short of Votes Needed to Override a Presidential Veto

Role of Stem Cells in Research continued...

The issue recently caused a split in Bush administration ranks. Last month, National Institutes of Health (NIH) Director Elias Zerhouni, MD, called White House limits on embryonic stem cell research "shortsighted" and suggesting the nation would benefit if the policy were reversed.

"It is clear today that American science will be better served and the nation will be better served if we let our scientists have access to more cell lines," Zerhouni told a Senate committee on March 19.

Zerhouni later played down the importance of the remarks. But supporters of the research on Capitol Hill quickly pointed out that it was the first time Zerhouni, a Bush political appointee, had publicly criticized the policy after years of voicing support for it.

It is unclear whether the Senate will muster enough votes to override a veto. Sen. Tim Johnson, D-N.D., supports the repeal but did not vote because he is recovering from a brain hemorrhage. Supporters are hoping to put enough pressure on lawmakers in moderate states in the hopes that one or two more will switch sides.

The House is likely to soon vote again on the issue. The Senate added a provision to its bill requiring the NIH to fund research into methods of extracting human stem cells without destroying embryos. Before the bill goes to the president, the House will have to pass its bill with the new provision included.


Today on WebMD

Parkinsons disease illustration
Causes, symptoms, and treatments.
hands on walker
How does the disease progress?
man with serious expression
8 common questions and answers.
intelligence quotient illustration
What are the advantages of DBS?
Parkinsons Disease Medications
Questions Doctor Parkinsons
Eating Right
Parkinsons Exercise
daughter consoling depressed mother
senior man's hands
Parkinsons Daily